(Hypertension. 2002;39:394.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology and Toxicology, Michigan State University, East Lansing.
Reprint requests to Dr Amy Banes, Department of Pharmacology and Toxicology, Michigan State University, B445 Life Sciences Bldg, East Lansing, MI 48824. E-mail banesamy{at}msu.edu
Previous studies have established a role for 5-hydroxytryptamine (5-HT)2B and 5-HT1B receptors in mediating enhanced contraction to serotonin (5-HT) in arteries from hypertensive deoxycorticosterone acetate (DOCA)-salt rats. To determine whether the observed increase in responsiveness was due to upregulation of 5-HT receptors, we used Western analysis to measure 5-HT1B and 5-HT2B receptor protein density. In endothelium-denuded aortas from hypertensive DOCA-salt rats (mean systolic blood pressure 192±6 mm Hg), 5-HT1B and 5-HT2B receptor proteins were upregulated
2-fold compared with the response in the aortas of sham-operated control rats (mean systolic blood pressure 119±2 mm Hg). Contraction to 5-HT2B receptor agonists was also enhanced in arteries from Wistar-Furth rats given DOCA and salt. This strain is relatively resistant to the hypertensive effects of DOCA and salt treatment. A common factor between the model of DOCA-salt hypertension and the DOCA-salttreated Wistar-Furth rats is the presence of mineralocorticoids. Therefore, we tested the hypothesis that mineralocorticoids can upregulate 5-HT1B and 5-HT2B receptors. Aortas from normal Sprague-Dawley rats were incubated with aldosterone (100 nmol/L) for 8, 12, 24, and 48 hours. The expression of 5-HT2B and 5-HT1B receptor proteins was significantly increased (
2- fold over vehicle treatment) by 8 hours. 5-HT2B and 5-HT1B receptors were upregulated by aldosterone in a concentration-dependent manner, and incubation with spironolactone (10 µmol/L) blocked this upregulation. These data support the conclusion that the increased expression of 5-HT1B and 5-HT2B receptors observed in arteries from DOCA-salt rats may be partially due to mineralocorticoids acting via the mineralocorticoid receptor to modulate gene expression.
Key Words: serotonin aldosterone arteries hypertension, sodium-dependent receptors, serotonin
This article has been cited by other articles:
![]() |
S. W. Watts The love of a lifetime: 5-HT in the cardiovascular system Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R252 - R256. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ni, G. D. Fink, and S. W. Watts The 5-Hydroxytryptamine2A Receptor Is Involved in (+)-Norfenfluramine-Induced Arterial Contraction and Blood Pressure Increase in Deoxycorticosterone Acetate-Salt Hypertension J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 485 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Erdely, G. Freshour, Y.-L. Tain, K. Engels, and C. Baylis DOCA/NaCl-induced chronic kidney disease: a comparison of renal nitric oxide production in resistant and susceptible rat strains Am J Physiol Renal Physiol, January 1, 2007; 292(1): F192 - F196. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ogden, J. M. Thompson, Z. Hickner, T. Huang, D. D. Tang, and S. W. Watts A new signaling paradigm for serotonin: use of Crk-associated substrate in arterial contraction Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2857 - H2863. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Liang, L.-P. Lai, B.-W. Wang, S.-J. Juang, C.-M. Chang, J.-G. Leu, and K.-G. Shyu Mechanical stress enhances serotonin 2B receptor modulating brain natriuretic peptide through nuclear factor-{kappa}B in cardiomyocytes Cardiovasc Res, November 1, 2006; 72(2): 303 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. L. Banes, S. M. Shaw, A. Tawfik, B. P. Patel, S. Ogbi, D. Fulton, and M. B. Marrero Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin Am J Physiol Cell Physiol, April 1, 2005; 288(4): C805 - C812. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Watts and J. M. Thompson Characterization of the Contractile 5-Hydroxytryptamine Receptor in the Renal Artery of the Normotensive Rat J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 165 - 172. [Abstract] [Full Text] |
||||
![]() |
A. Russell, A. Banes, H. Berlin, G. D. Fink, and S. W. Watts 5-Hydroxytryptamine2B Receptor Function Is Enhanced in the Nomega -Nitro-L-arginine Hypertensive Rat J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 179 - 187. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |